Lithium Use, but Not Valproate Use, Is Associated With a Higher Risk of Chronic Kidney Disease in Older Adults With Mental Illness
The DOI matches its Crossref record.
Abstract
OBJECTIVE: Lithium is an essential mood disorder treatment; however, it remains unclear whether lithium increases chronic kidney disease (CKD) risk. There are few data on this in the elderly, even though older adults may be particularly susceptible to CKD. We wished to determine whether lithium is associated with increased CKD risk relative to valproate in older adults. METHODS: This nested case-control study analyzed province-wide administrative health data from mental health service users aged ≥ 66 years in Ontario, Canada, from 2003 to 2014. Five-year incident CKD risk was compared in lithium users, valproate users, and patients who used neither medication. ICD-10 was used to assign CKD diagnosis. We used conditional logistic regression to control for hypertension, diabetes mellitus, acute kidney injury, medications associated with lithium toxicity, and other potential confounders. RESULTS: 21,741 cases and 86,930 age- and sex-matched controls were identified, including 529 lithium users and 498 valproate users. After controlling for confounders, we found that lithium use was associated with increased risk of incident CKD (adjusted odds ratio [OR] = 1.76 [95% CI, 1.41-2.19]), while valproate use was not (adjusted OR = 1.03 [95% CI, 0.81-1.29]). CONCLUSIONS: Lithium is independently associated with an almost 2-fold increase in CKD risk in this community sample of older mental health service users. In the absence of clear information about certain contributing factors, such as inadequate monitoring and acute and chronic lithium level elevations, causes for this increase will need to be determined in future research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lithium use is associated with a two‐fold higher risk of chronic kidney disease in older adults (>66 years).822”
Citations
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationShulman, K. I., Almeida, O. P., Herrmann, N., Schaffer, A., Strejilevich, S. A., Paternoster, C., Amodeo, S., Dols, A., & Sajatovic, M. (2019) · Bipolar Disorders · doi:10.1111/bdi.12714 · Cited by 86
Self-citationUsing Lithium in Older Age Bipolar Disorder: Special Considerations
Soh, J. F., Klil‐Drori, S., & Rej, S. (2019) · Drugs & Aging · doi:10.1007/s40266-018-0628-1 · Cited by 62
Self-citationPsychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research
Damba, J. J., Bodenstein, K., Lavín, P., Drury, J., Sekhon, H., Renoux, C., Trinh, E., Rej, S., & Greenway, K. T. (2022) · CNS Drugs · doi:10.1007/s40263-022-00952-y · Cited by 42
“Most study designs utilized antiepileptic users as a control group to lithium users [28, 30, 44, 47, 54, 55, 57], and thus explored the hypothesis that antiepileptics are less harmful than lithium rather than not harmful.”
BackgroundMethodInfluentialSelf-citationAbsolute and Relative Risks of Kidney Outcomes Associated With Lithium vs Valproate Use in Sweden
Bosi, A., Clase, C. M., Ceriani, L., Sjölander, A., Fu, E. L., Runesson, B., Chang, Z., Landén, M., Bellocco, R., Elinder, C., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.22056 · Cited by 38
Metadata
- Authors
- Rej, S., Herrmann, N., Shulman, K., Fischer, H. D., Fung, K., Harel, Z., & Gruneir, A.
- Affiliations
- Sunnybrook Health Science Centre (CA)
- Institute for Clinical Evaluative Sciences (CA)
- Women's College Hospital (CA)
- St. Michael's Hospital (CA)
- University of Alberta (CA)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2017-10-25
- Volume
- 78
- Issue
- 8
- Pages
- e980-e985
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2740971634
- Cited by
- 17
- References
- 0
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 3
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- lithium, valproic acid, chronic kidney disease, older adults, mental illness, mood disorders, antipsychotic safety, lithium nephrotoxicity, lithium toxicity, incident CKD risk
- MeSH terms
- Aged, Mental Disorders, Canada, Female, Humans, Male, Mental Health Services, Valproic Acid, Case-Control Studies, Drug Monitoring, Lithium Compounds, Risk Assessment, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lithium Use, but Not Valproate Use, Is Associated With a Higher Risk of Chronic Kidney Disease in Older Adults With Mental Illness. https://app.cochat.ai/papers/10.4088/jcp.16m11125
- The paper
- Rej, S., Herrmann, N., Shulman, K., Fischer, H. D., Fung, K., Harel, Z., & Gruneir, A. (2017). Lithium Use, but Not Valproate Use, Is Associated With a Higher Risk of Chronic Kidney Disease in Older Adults With Mental Illness. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.16m11125
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.